Product Information
OSELTAMIVIR PHOS 75 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.7962 per EA under NDC 33342025866. Its NADAC has been published 447 times since Mar 14, 2018.
FDA first approved this application on Sep 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342025866
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA207211FDA Approved
9/14/2017
TE Code
AB
On Market Since
9/21/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has been published 447 times since Mar 14, 2018, and over the history we have for it it has declined 90.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7962 per EA |
|---|---|
| All-time high | $8.3077 (Jun 13, 2018) |
| All-time low | $0.7575 (Nov 20, 2024) |
| 52-week high | $0.9163 |
| 52-week low | $0.7962 |
| Median price | $1.4082 |
| Average price | $2.2977 |
| Largest weekly change | -37.2% (Sep 22, 2021) |
| Weeks tracked | 447 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
oseltamivir phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 75 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.7962 per EA (NDC 33342025866), effective Sep 30, 2026.
How has the price of OSELTAMIVIR PHOS 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has declined 90.4%. It has been tracked across 447 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 75 MG CAPSULE?
Since Mar 14, 2018, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has ranged from a low of $0.7575 (Nov 20, 2024) to a high of $8.3077 (Jun 13, 2018), with a median of $1.4082 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 75 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 75 MG CAPSULE?
OSELTAMIVIR PHOS 75 MG CAPSULE (NDC 33342025866) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.